Mechanistically, TMAO could bind to hypoxia-inducible factor 1 alpha (HIF1α) at 235–238 sites, which promoted oxidative stress through the inhibition of HIF1α signal, thereby aggravating AD pathology. The gene discussed is HIF1A; the disease is Alzheimer disease.